These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17540954)

  • 1. Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study.
    Raitakari OT; Rönnemaa T; Huupponen R; Viikari L; Fan M; Marniemi J; Hutri-Kähönen N; Viikari JS; Lehtimäki T
    Diabetes Care; 2007 Sep; 30(9):2299-301. PubMed ID: 17540954
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription factor 7-like 2-gene polymorphism is related to fasting C peptide in latent autoimmune diabetes in adults (LADA).
    Szepietowska B; Moczulski D; Wawrusiewicz-Kurylonek N; Grzeszczak W; Gorska M; Szelachowska M
    Acta Diabetol; 2010 Mar; 47(1):83-6. PubMed ID: 19533015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
    Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
    Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
    Thorsby PM; Midthjell K; Gjerlaugsen N; Holmen J; Hanssen KF; Birkeland KI; Berg JP
    Scand J Clin Lab Invest; 2009; 69(2):282-7. PubMed ID: 18972257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
    Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
    Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on: Chang et al. (2007) Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population: Diabetes 56:2631-2637.
    Ku CS; Khaw M; Chia KS
    Diabetes; 2007 Dec; 56(12):e22; author reply e23. PubMed ID: 18042757
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk.
    Fisher E; Boeing H; Fritsche A; Doering F; Joost HG; Schulze MB
    Br J Nutr; 2009 Feb; 101(4):478-81. PubMed ID: 19149908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCF7L2 polymorphism rs7903146 and predisposition for type 2 diabetes mellitus in obese children.
    Roth CL; Hinney A; Reinehr T; Schreiner F; Nguyen TT; Müller T; Scholl C; Woelfle J; Karpushova A; Schäfer H; Nöthen MM; Hebebrand J
    Horm Metab Res; 2008 Oct; 40(10):713-7. PubMed ID: 18546086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H; Hadaegh F; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new type 2 diabetes gene TCF7L2.
    Florez JC
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):391-6. PubMed ID: 17563454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study: response to Kramer et al.
    Oda E; Kawai R
    Diabetes Care; 2009 Oct; 32(10):e125; author reply e126. PubMed ID: 19793999
    [No Abstract]   [Full Text] [Related]  

  • 16. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.
    Kang ES; Kim MS; Kim YS; Hur KY; Han SJ; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
    Diabetes Care; 2008 Jan; 31(1):63-8. PubMed ID: 17934151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of TCF7L2.
    Weedon MN
    Diabet Med; 2007 Oct; 24(10):1062-6. PubMed ID: 17888129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the gene or testing a variant? The case of TCF7L2.
    Goodarzi MO; Rotter JI
    Diabetes; 2007 Oct; 56(10):2417-9. PubMed ID: 17901222
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.